[1]
2025. SAFETY SIGNALS FOR HYPERKALEMIA IN TYPE 2 DIABETES: A FOCUSED REVIEW OF SGLT-2, GLP-1, AND DPP-4 DRUG CLASSES. Journal of Medical & Health Sciences Review. 2, 3 (Jul. 2025), 3711–3716. DOI:https://doi.org/10.62019/sw57nf20.